United Services Automobile Association’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,343
| Closed | -$882K | – | 148 |
|
|
2025
Q1 | $882K | Hold |
12,343
| – | – | 0.03% | 310 |
|
|
2024
Q4 | $811K | Hold |
12,343
| – | – | 0.03% | 235 |
|
|
2024
Q3 | $868K | Sell |
12,343
-2,468
| -17% | -$206K | 0.02% | 221 |
|
|
2024
Q2 | $1.22M | Buy |
+14,811
| New | +$1.23M | 0.03% | 198 |
|
|
2021
Q1 | – | Sell |
-13,930
| Closed | -$1.12M | – | 168 |
|
|
2020
Q4 | $1.12M | Buy |
+13,930
| New | +$1.1M | 0.02% | 175 |
|
|
2020
Q3 | – | Sell |
-13,930
| Closed | -$1.12M | – | 176 |
|
|
2020
Q2 | $1.12M | Sell |
13,930
-38,561
| -73% | -$3.83M | 0.02% | 175 |
|
|
2020
Q1 | $4.61M | Buy |
52,491
+1,383
| +3% | +$119K | 0.06% | 142 |
|
|
2019
Q4 | $4.27M | Sell |
51,108
-4,742
| -8% | -$358K | 0.05% | 163 |
|
|
2019
Q3 | $3.76M | Sell |
55,850
-74,418
| -57% | -$5.73M | 0.05% | 186 |
|
|
2019
Q2 | $11.2M | Buy |
130,268
+57,366
| +79% | +$4.91M | 0.03% | 513 |
|
|
2019
Q1 | $6.48M | Buy |
72,902
+216
| +0.3% | +$20K | 0.02% | 688 |
|
|
2018
Q4 | $6.19M | Buy |
72,686
+2,903
| +4% | +$276K | 0.02% | 672 |
|
|
2018
Q3 | $6.77M | Buy |
69,783
+1,629
| +2% | +$163K | 0.02% | 710 |
|
|
2018
Q2 | $6.42M | Buy |
68,154
+906
| +1% | +$79.3K | 0.02% | 712 |
|
|
2018
Q1 | $5.45M | Buy |
67,248
+28,858
| +75% | +$2.48M | 0.01% | 790 |
|
|
2017
Q4 | $3.42M | Buy |
38,390
+1,539
| +4% | +$134K | 0.01% | 921 |
|
|
2017
Q3 | $3.43M | Buy |
36,851
+1,497
| +4% | +$132K | 0.01% | 891 |
|
|
2017
Q2 | $3.21M | Buy |
35,354
+1,743
| +5% | +$159K | 0.01% | 891 |
|
|
2017
Q1 | $2.95M | Buy |
33,611
+1,253
| +4% | +$111K | 0.01% | 900 |
|
|
2016
Q4 | $2.68M | Buy |
32,358
+1,269
| +4% | +$109K | 0.01% | 917 |
|
|
2016
Q3 | $2.88M | Buy |
31,089
+1,682
| +6% | +$158K | 0.01% | 891 |
|
|
2016
Q2 | $2.29M | Buy |
29,407
+806
| +3% | +$68.5K | 0.01% | 904 |
|
|
2016
Q1 | $2.36M | Sell |
28,601
-37,489
| -57% | -$3.05M | 0.01% | 877 |
|
|
2015
Q4 | $6.92M | Buy |
66,090
+39,858
| +152% | +$4.16M | 0.02% | 590 |
|
|
2015
Q3 | $2.76M | Buy |
+26,232
| New | +$3.5M | 0.01% | 844 |
|
|
2014
Q2 | – | Sell |
-93,910
| Closed | -$6.41M | – | 1236 |
|
|
2014
Q1 | $6.41M | Buy |
+93,910
| New | +$6.92M | 0.02% | 610 |
|
|
2013
Q4 | – | Sell |
-35,200
| Closed | -$2.54M | – | 1231 |
|
|
2013
Q3 | $2.54M | Buy |
35,200
+900
| +3% | +$59.8K | 0.01% | 860 |
|
|
2013
Q2 | $1.91M | Buy |
+34,300
| New | +$2.14M | 0.01% | 886 |
|
Other funds holding BMRN
United Services Automobile Association's BMRN Position: Q2 2025 in Review
United Services Automobile Association sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2025, closing a stake of 12,343 shares — an estimated $882K sold.
United Services Automobile Association first reported a position in BMRN in Q2 2013 and held it in 28 quarters. The position peaked at $11.2M in Q2 2019. 581 funds tracked by Wall St. Rank hold BMRN as of Q2 2025.
- United Services Automobile Association reported no remaining BioMarin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- United Services Automobile Association sold 12,343 BioMarin Pharmaceuticals shares in Q2 2025, an estimated $882K.
- United Services Automobile Association first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 28 quarters.
- United Services Automobile Association's BioMarin Pharmaceuticals position peaked at $11.2M in Q2 2019.
- 581 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2025.
Based on United Services Automobile Association's 13F filing for Q2 2025, filed 15 Aug 2025.